GENESEN
Genesen is developing peptide-based new drugs that provides the treatment of autoimmune and inflammatory diseases.
GENESEN
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2018-01-01
Address:
Seoul, Seoul-t'ukpyolsi, South Korea
Country:
South Korea
Website Url:
http://www.genesenbio.com
Total Employee:
11+
Status:
Active
Contact:
02-569-3738
Email Addresses:
[email protected]
Total Funding:
1.9 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Mobile Non Scaleable Content Euro Google Maps ASP.NET IIS Pound Sterling IIS 10
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focusesย on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
ValenzaBio
ValenzaBio is developing safe and effective treatment options for patients with autoimmune and inflammatory diseases.
Current Employees Featured
More informations about "Genesen"
Genesen - Crunchbase Company Profile & Funding
Organization. Genesen . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email [email protected]; Phone Number โฆSee details»
Genesen Company Profile 2024: Valuation, Funding & Investors
Genesen General Information Description. Developer of peptide drug designed for the treatment of autoimmune and inflammatory diseases. The company specializes in biopharmaceutical โฆSee details»
Genesen Company Profile - Office Locations, Competitors ... - Craft
Genesen has 5 employees at their 1 location and $1.9 m in total funding,. See insights on Genesen including office locations, competitors, revenue, financials, executives, subsidiaries โฆSee details»
Genesen - Products, Competitors, Financials, Employees, โฆ
Genesenbio.com. Overview & Products; Financials; People; Founded Year 2018. Stage Seed VC | Alive. Total Raised $1.89M. Last Raised $1.89M | 5 yrs ago. About Genesen. Genesen is a โฆSee details»
Genesen - Company Profile - Tracxn
Genesen ranks 182nd among 242 active competitors. 93 of its competitors are funded while 51 have exited. Overall, Genesen and its competitors have raised over $12.7B in funding across โฆSee details»
Genesen Co. Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Genesen Co. Ltd. with its drug pipeline, therapeutic area, technology platform, .See details»
Genesen - Overview, News & Competitors | ZoomInfo.com
View Genesen (www.genesenbio.com) location in Provence-Alpes-Cote d'Azur, France , revenue, industry and description. Find related and similar companies as well as employees by title and โฆSee details»
Genesen - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Jan 8, 2020:See details»
Genesen - LinkedIn
Genesen | 36 followers on LinkedIn. ... ุงูุนุฑุจูุฉ (Arabic) เฆฌเฆพเฆเฆฒเฆพ (Bangla) ฤeลกtina (Czech)See details»
Genesen - Contacts, Employees, Board Members, Advisors & Alumni
Genesen is developing peptide-based new drugs that provides the treatment of autoimmune and inflammatory diseases.See details»
Sung Ho Lee - CEO - Genesen Co.,LTD (์ฃผ)์ ์ผ | LinkedIn
Genesen ltd (์ฃผ)์ ์ผ CEO · Majored in Protein Biochemistry<br><br>Eyegen Inc. R&D Department, Senior Scientist, Director 2000-2004<br> - Development of disease treatment โฆSee details»
Genesen - Company Information, Competitors, News & FAQs
Find useful insights on Genesen's company details, tech stack, news alerts, competitors and more. Use 6sense to connect with top decision-makers at Genesen.See details»
Genesen Inc. - Pharmaceuticals - Genesen Inc. - LinkedIn
The therapeutics effect of GSP-1 is proved by in vitro and in vivo experiments, and the pre-clinical development, ADME study, collaboration with our partners are planned to prepare IND โฆSee details»
Genesen secures $1.9M for peptide-based autoimmune disease
Jan 14, 2020 HONG KONG โ South Korean biopharma Genesen Inc. has secured โฉ2.2 billion (US$1.9 million) in seed funding to advance its peptide-based drug candidates for the โฆSee details»
์คํํธ์ DB ์ ์ผ | ํ๊ตญ๊ฒฝ์ - ํ๊ฒฝ๋ท์ปด
์คํํธ์ DB ์ ์ผ, ํ๊ฒฝ ๊ธฑ์ค๋ ํ์ ์ ๋ชฐ์ ํ๊ณ ๋ฏธ๋๋ฅผ ๋ฐ๊พธ๋ ๋ค์ํ ๊ธฑ(๊ดด์ง)๋ค์ ์ด์ผ๊ธฐ๋ฅผ ๋ค๋ฃน๋๋ค.See details»
์ ์ผ(์๊ฐ๋ฉด์ญ์งํ ์น๋ฃ์ ) - ๊ธฐ์ ์ ๋ณด | ํฌ์, ๋งค์ถ, ๊ธฐ์ ๊ฐ์น - THE VC
์ฃผ์ํ์ฌ ์ ์ผ(genesen)์ 2018๋ 7์์ ์ค๋ฆฝ๋ ํ๊ตญ๊ณโ์คํํธ์ ์ ๋๋ค. ๋ฐ์ด์ค/์๋ฃโ๋ฉด์ญ์งํ ๋ถ์ผ์ ์๊ฐ๋ฉด์ญ์งํ ์น๋ฃ์ ๊ฐ ์ฃผ์ ์ ํ/์๋น์ค์ ๋๋ค. ๋ณธ์ฌ๋ ํ๊ตญโ์์ธํน๋ณ์์ โฆSee details»
Core Values - Genezen
Our values are a part of our DNA. Genezen was founded to serve as a trusted partner between therapeutic companies and academic vector cores. Throughout our remarkable evolution, we โฆSee details»
Genezen - Crunchbase Company Profile & Funding
Genezen offers contract process development, GMP viral vector production, transduced cell manufacturing, and testing services.See details»
With new facility and leadership, CDMO Genezen is stepping up to โฆ
Sep 17, 2021 Construction is underway on the 75,000-square-foot lentiviral and retroviral vector production facility. Genezen expects the site to come online in the first half of 2022, after โฆSee details»
Biogen Canadaโs Marina Vasiliou: A 100% Commitment to โฆ
Jul 11, 2019 Marina Vasiliou took the reins as managing director of Biogen Canada in November 2017 after a long and varied career at MSD in a wide variety of geographies.See details»